{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:17:18Z","timestamp":1788585438423,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"DOI":"10.7759\/cureus.115799","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:50:16Z","timestamp":1788583816000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Age and Spherical Equivalent With Differences in Cycloplegic Refractive Effects Between Cyclopentolate and Atropine"],"prefix":"10.7759","author":[{"given":"Toru","family":"Kawanobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Goseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiko","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-1622","article-title":"Advances in amblyopia: what have we learned from PEDIG trials?","volume":"131","author":"Gunton KB","year":"2013","unstructured":"Gunton KB. Advances in amblyopia: what have we learned from PEDIG trials?. Pediatrics. 2013, 131:540-7. 10.1542\/peds.2012-1622","journal-title":"Pediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2017.00082","article-title":"Revisiting vision rehabilitation","volume":"11","author":"Meyniel C","year":"2017","unstructured":"Meyniel C, Bodaghi B, Robert PY. Revisiting vision rehabilitation. Front Syst Neurosci. 2017, 11:82. 10.3389\/fnsys.2017.00082","journal-title":"Front Syst Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.819998","article-title":"The global prevalence of amblyopia in children: a systematic review and meta-analysis","volume":"10","author":"Hu B","year":"2022","unstructured":"Hu B, Liu Z, Zhao J, Zeng L, Hao G, Shui D, Mao K. The global prevalence of amblyopia in children: a systematic review and meta-analysis. Front Pediatr. 2022, 10:819998. 10.3389\/fped.2022.819998","journal-title":"Front Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.0539","article-title":"Association of strabismus with functional vision and eye-related quality of life in children","volume":"138","author":"Hatt SR","year":"2020","unstructured":"Hatt SR, Leske DA, Casta\u00f1eda YS, et al.. Association of strabismus with functional vision and eye-related quality of life in children. JAMA Ophthalmol. 2020, 138:528-35. 10.1001\/jamaophthalmol.2020.0539","journal-title":"JAMA Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/09273972.2019.1604773","article-title":"Global and regional prevalence of strabismus: a comprehensive systematic review and meta-analysis","volume":"27","author":"Hashemi H","year":"2019","unstructured":"Hashemi H, Pakzad R, Heydarian S, et al.. Global and regional prevalence of strabismus: a comprehensive systematic review and meta-analysis. Strabismus. 2019, 27:54-65. 10.1080\/09273972.2019.1604773","journal-title":"Strabismus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S388982","article-title":"Ocular cyclopentolate: a mini review concerning its benefits and risks","volume":"16","author":"Contreras-Salinas H","year":"2022","unstructured":"Contreras-Salinas H, Orozco-Ceja V, Romero-L\u00f3pez MS, Barajas-Virgen MY, Baiza-Dur\u00e1n LM, Rodr\u00edguez-Herrera LY. Ocular cyclopentolate: a mini review concerning its benefits and risks. Clin Ophthalmol. 2022, 16:3753-62. 10.2147\/OPTH.S388982","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312199","article-title":"Cycloplegic refraction by 1% cyclopentolate in young adults: is it the gold standard? The Anyang University Students Eye Study (AUSES)","volume":"103","author":"Sun YY","year":"2018","unstructured":"Sun YY, Wei SF, Li SM, et al.. Cycloplegic refraction by 1% cyclopentolate in young adults: is it the gold standard? The Anyang University Students Eye Study (AUSES). Br J Ophthalmol. 2018, 103:654-8. 10.1136\/bjophthalmol-2018-312199","journal-title":"Br J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0300-1652.184065","article-title":"Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia","volume":"57","author":"Sani RY","year":"2016","unstructured":"Sani RY, Hassan S, Habib SG, Ifeanyichukwu EP. Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia. Niger Med J. 2016, 57:173-7. 10.4103\/0300-1652.184065","journal-title":"Niger Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00863.x","article-title":"Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides","volume":"32","author":"Fan DS","year":"2004","unstructured":"Fan DS, Rao SK, Ng JS, Yu CB, Lam DS. Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Clin Exp Ophthalmol. 2004, 32:462-7. 10.1111\/j.1442-9071.2004.00863.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/OPTO.S217645","article-title":"Cycloplegia in children: an optometrist's perspective","volume":"12","author":"Major E","year":"2020","unstructured":"Major E, Dutson T, Moshirfar M. Cycloplegia in children: an optometrist's perspective. Clin Optom (Auckl). 2020, 12:129-33. 10.2147\/OPTO.S217645","journal-title":"Clin Optom (Auckl)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-018-0612-7","article-title":"Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study","volume":"62","author":"Wakayama A","year":"2018","unstructured":"Wakayama A, Nishina S, Miki A, et al.. Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study. Jpn J Ophthalmol. 2018, 62:531-6. 10.1007\/s10384-018-0612-7","journal-title":"Jpn J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.3.268","article-title":"A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children","volume":"120","author":"The Pediatric Eye Disease Investigator Group","year":"2002","unstructured":"The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002, 120:268-78. 10.1001\/archopht.120.3.268","journal-title":"Arch Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.04.032","article-title":"A randomized trial of atropine regimens for treatment of moderate amblyopia in children","volume":"111","author":"Repka MX","year":"2004","unstructured":"Repka MX, Cotter SA, Beck RW, et al.. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004, 111:2076-85. 10.1016\/j.ophtha.2004.04.032","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia A","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012, 119:347-54. 10.1016\/j.ophtha.2011.07.031","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112142-20200622-00413","article-title":"The safety of atropine for myopia prevention and control. (Article in Chinese)","volume":"57","author":"Chen DX","year":"2021","unstructured":"Chen DX, He XG, Xu X. The safety of atropine for myopia prevention and control. (Article in Chinese). Zhonghua Yan Ke Za Zhi. 2021, 57:299-304. 10.3760\/cma.j.cn112142-20200622-00413","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2025.3243","article-title":"Atropine or cyclopentolate to diagnose premyopia in preschool children","volume":"143","author":"Wu H","year":"2025","unstructured":"Wu H, Wang Y, Lu Q, et al.. Atropine or cyclopentolate to diagnose premyopia in preschool children. JAMA Ophthalmol. 2025, 143:904-13. 10.1001\/jamaophthalmol.2025.3243","journal-title":"JAMA Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_1159_23","article-title":"Comparison of cycloplegia with atropine 1% versus cyclopentolate 1","volume":"71","author":"Singh RP","year":"2023","unstructured":"Singh RP, Amitava AK, Sharma N, Gupta Y, Raza SA, Bose A, Meena GS. Comparison of cycloplegia with atropine 1% versus cyclopentolate 1. Indian J Ophthalmol. 2023, 71:3633-6. 10.4103\/IJO.IJO_1159_23","journal-title":"Indian J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7997186\/v1","article-title":"Association of age and spherical equivalent with differences in cycloplegic refractive effects between cyclopentolate and atropine","author":"Kawanobe T","year":"2025","unstructured":"Kawanobe T, Goseki T, Takahashi S, et al.. Association of age and spherical equivalent with differences in cycloplegic refractive effects between cyclopentolate and atropine. Res Sq. 2025, 10.21203\/rs.3.rs-7997186\/v1","journal-title":"Res Sq"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000239","article-title":"Cycloplegic refraction in children with cyclopentolate versus atropine","volume":"3","author":"Farhood QK","year":"2012","unstructured":"Farhood QK. Cycloplegic refraction in children with cyclopentolate versus atropine. J Clin Exp Ophthalmol. 2012, 3:239. 10.4172\/2155-9570.1000239","journal-title":"J Clin Exp Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(81)80032-2","article-title":"Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine","volume":"88","author":"Rosenbaum AL","year":"1981","unstructured":"Rosenbaum AL, Bateman JB, Bremer DL, Liu PY. Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine. Ophthalmology. 1981, 88:1031-4. 10.1016\/s0161-6420(81)80032-2","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278269","article-title":"Effect of six different autorefractor designs on the precision and accuracy of refractive error measurement","volume":"17","author":"Venkataraman AP","year":"2022","unstructured":"Venkataraman AP, Brautaset R, Dom\u00ednguez-Vicent A. Effect of six different autorefractor designs on the precision and accuracy of refractive error measurement. PLoS One. 2022, 17:e0278269. 10.1371\/journal.pone.0278269","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2022.60","article-title":"Comparison of the results of four different refraction measurement devices in children with retinoscopy","volume":"66","author":"Simsek M","year":"2022","unstructured":"Simsek M, Oral Y, Erogul O, Sabaner MC, Simsek C, Yorukoglu S. Comparison of the results of four different refraction measurement devices in children with retinoscopy. Rom J Ophthalmol. 2022, 66:337-43. 10.22336\/rjo.2022.60","journal-title":"Rom J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/525924-association-of-age-and-spherical-equivalent-with-differences-in-cycloplegic-refractive-effects-between-cyclopentolate-and-atropine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:50:23Z","timestamp":1788583823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/525924-association-of-age-and-spherical-equivalent-with-differences-in-cycloplegic-refractive-effects-between-cyclopentolate-and-atropine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.115799","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}